Your browser doesn't support javascript.
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.
Davis, James A; Granger, Katelynn; Roubal, Kiera; Smith, Deidra; Gaffney, Kelly J; McGann, Mary; Cendagorta, Alyssa M; Thurlapati, Aswani; Herbst, Amanda; Hendrickson, Lindsey; Hashmi, Hamza; Hess, Brian T.
  • Davis JA; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Granger K; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Roubal K; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Smith D; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Gaffney KJ; Medical University of South Carolina, Charleston, South Carolina, United States.
  • McGann M; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Cendagorta AM; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Thurlapati A; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Herbst A; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Hendrickson L; Medical University of South Carolina, Charleston, South Carolina, United States.
  • Hashmi H; Medical University of South Carolina, Charleston, South Carolina, Falkland Islands.
  • Hess BT; The Medical University of South Carolina, Charleston, South Carolina, United States.
Blood ; 2022 Nov 04.
Article in English | MEDLINE | ID: covidwho-2229315

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2022 Document Type: Article Affiliation country: Blood.2022018283

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2022 Document Type: Article Affiliation country: Blood.2022018283